Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate the effectiveness of Rotarixâ„¢ vaccine in the general population in Singapore by monitoring the overall reduction in RV SGE and also by assessing the direct protection offered by the vaccine in hospitalised infants through a case-control study.
This Protocol Posting has been updated following an amendment of the Protocol.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | Cases |
| |
| Group B | Controls |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Collection of information | Other | Information regarding demographic characteristics, medical history, previous participation in rotavirus clinical trials and vaccination history will be collected. |
| Measure | Description | Time Frame |
|---|---|---|
| To estimate the proportion of acute RV GE hospitalisations in children < 5 years of age. | At least one year | |
| To estimate the effectiveness of two doses of Rotarixâ„¢ vaccination in preventing rotavirus severe gastroenteritis (RV SGE) among children born after 1 November 2005 and aged at least 16 weeks. | At least one year |
| Measure | Description | Time Frame |
|---|---|---|
| To estimate the effectiveness of two doses of Rotarixâ„¢ vaccination in preventing hospitalisation for acute RV GE among children born after 1 November 2005 and aged at least 16 weeks. | At least one year | |
| To determine the distributions of acute RV GE associated hospital admissions according to subject's age, gender and by month of year. |
Not provided
Inclusion Criteria:
Inclusion criteria for surveillance subjects
Cases will be limited to those surveillance subjects:
All controls must satisfy the following criteria at study entry:
Exclusion Criteria:
For enrolment of surveillance subjects
The following criteria should be checked at the time of study entry. If any apply, the subject must not be included in the study:
In addition to the exclusion criteria for surveillance subjects, cases will not be selected if the following criterion applies:
The following criteria should be checked at the time of study entry. If any apply, the controls must not be included in the study:
Not provided
Not provided
Not provided
Children less than 5 years of age, hospitalised with acute GE, living in Singapore served by the hospital participating in the study (KK Hospital) and whose parents/ guardians are willing to provide informed consent, will be considered as cases.
Cases will be limited to those subjects who are born after 1 November 2005, aged at least 16 weeks and whose stool samples have been tested positive for rotavirus (RV).
For each case, two controls hospitalised for acute disease with non-GE causes in the same hospital during the same period, will be included in the study after matching them by date of birth.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| GSK Clinical Trials | GlaxoSmithKline | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Singapore | 229899 | Singapore |
Not provided
Not provided
Not provided
Not provided
Stool samples
| Collection of stool samples | Procedure | Stools samples will be collected during hospitalisation for RV testing and genotyping of RV positive samples. |
|
| At least one year |
| To estimate the prevalence of RV genotypes in acute RV GE associated hospital admission. | At least one year |
| To review the trend of acute RV GE and acute GE admissions over the entire study period. | At least one year |